![]() |
市場調查報告書
商品編碼
1476346
到 2030 年獸醫參考實驗室市場預測:按服務類型、動物類型、應用、最終用戶和地區進行的全球分析Veterinary Reference Laboratory Market Forecasts to 2030 - Global Analysis By Service Type, Animal Type, Application, End User and by Geography |
根據 Stratistics MRC 的數據,2023 年全球獸醫參考實驗室市場規模為 45.6 億美元,預計到 2030 年將達到 96.5 億美元,預測期內複合年成長率為 11.3%。
獸醫參考實驗室 (VRL) 是一個專業設施,擁有最先進的設備和高素質的獸醫專業人員,致力於診斷和追蹤動物的健康狀況。血液化學分析、微生物學、病理學和基因檢測只是 VRL 幫助診斷和治療各種動物疾病的眾多測試中的一小部分。 VRL 是保護動物健康、幫助研究並確保家畜和野生動物福利的重要資源。
英國獸醫協會 (BVA) 表示,獸醫專業人員致力於促進動物的健康和福祉、推動獸醫醫學發展並維護高標準的專業行為。
動物健康意識不斷增強
獸醫協會、動物福利組織和政府機構等相關人員擴大合作,以提高動物健康意識。這些計劃的目標是提高寵物飼主和牲畜生產者對定期獸醫檢查和預防性醫療保健措施價值的認知。此外,最近爆發的禽流感和牛腦病變(BSE)等備受矚目的疾病進一步強調了對強力的診斷服務的需求,並強調了損害動物健康和食品安全所帶來的風險。
尖端診斷技術成本高
獸醫參考實驗室在實施新診斷技術方面面臨重大財務障礙。購買最先進的設備(例如自動分析儀和次世代定序平台)相關的初始成本很高。由於設備升級、校準和維護的持續支出,營運成本也會增加。此外,需要雇用和維持能夠熟練使用和解釋這些最尖端科技產生的資料的合格員工,這進一步增加了財務負擔。
對專業診斷服務的需求不斷增加
獸醫學的日益複雜性以及動物感染疾病和慢性病發病率的上升為獸醫參考實驗室提供了擴大其服務範圍的機會。分子診斷、血清學和先進影像等專業診斷測試作為早期發現疾病、制定個人化治療計劃和監測治療效果的工具的需求不斷增加。此外,實驗室可以利用這一趨勢,透過投資尖端技術並提高基因檢測、感染疾病和腫瘤學等專業領域的能力,在市場中脫穎而出。
來自針對競爭對手的內部測試的壓力
為了提高交貨時間和客戶滿意度,獸醫醫院和診所正在增加診斷測試設備的內部投資。由於這一趨勢,獸醫參考實驗室陷入危機,因為委託給外部實驗室的診斷測試越來越少。獸醫院可能會發現院內檢測更實用、更經濟,特別是對於快速診斷檢測和常規篩檢檢測。然而,為了減少內部測試的競爭影響,獸醫參考實驗室必須透過提供專業測試、複雜病例知識和卓越的客戶服務來脫穎而出。
獸醫參考實驗室市場受到了 COVID-19 大流行的影響。儘管在大流行的早期階段,實驗室營運中斷、供應鏈挑戰以及封鎖措施和經濟不確定性減少了對非必要獸醫服務的需求,但大流行的下一階段是隨著趨勢的變化而逐步復甦。這次疫情凸顯了獸醫診斷在通用感染疾病監測、動物健康監測和食品安全方面的價值,並增加了對診斷檢測服務的需求。此外,由於疫情期間寵物飼養量的增加以及對動物健康和福利意識的增強,對健康檢查、疫苗接種和診斷篩檢等預防性醫療的需求也在增加。
在預測期內,臨床病理學領域預計將是最大的。
在獸醫參考實驗室產業,臨床病理學領域預計將佔據最大的市場佔有率。臨床病理學是一個廣泛的醫學領域,包括透過檢查動物的組織、細胞和體液來評估動物健康狀況的各種診斷程序。血液學、生物化學、尿液檢查、細胞學和組織病理學是其中的一些測試。此外,多種獸醫疾病的診斷、監測和治療,包括感染疾病、傳染性疾病、免疫介導疾病和腫瘤疾病,在很大程度上依賴臨床病理學。
預計製藥領域在預測期內複合年成長率最高
在獸醫參考實驗室市場,製藥公司領域預計將出現最高的複合年成長率。透過獸藥、疫苗和生物製藥的開發和開拓,製藥公司在獸藥領域發揮重要作用。我們依靠獸醫參考實驗室提供臨床前和臨床測試服務來評估我們產品的安全性、有效性和品質。此外,獸醫參考實驗室和製藥公司合作進行研究和開發計劃,以推進獸醫診斷和治療方法。
由於其強大的法律規範、最先進的診斷技術以及完善的獸醫醫療保健基礎設施(獸醫診所、醫院和研究機構高度集中),北美通常佔據最大佔有率。對診斷測試服務的需求部分是由於北美寵物擁有量的增加、對伴同性動物醫療保健服務的需求增加以及公眾對通用感染疾病的認知提高而推動的。此外,政府機構、獸醫協會和市場參與企業在推廣預防醫學和改善動物福利方面的刻意努力也有助於該地區獸醫參考實驗室市場的穩定擴張。
獸醫參考實驗室市場預計將以亞太地區最高的複合年成長率成長。新興經濟體,特別是中國、印度和東南亞國家,正在經歷快速的都市化、經濟發展和向伴同性動物養殖的轉變。可支配收入的增加、生活方式的變化以及寵物健康意識的提高正在推動該地區對獸醫健康服務(包括診斷測試)的需求。畜牧業生產的擴大以及對食品安全和疾病爆發的日益擔憂推動了獸醫保健中先進診斷技術的採用。此外,由於政府改善動物福利、加強法規結構和實現動物保健基礎設施現代化的舉措,亞太獸醫參考實驗室市場正在擴大。
According to Stratistics MRC, the Global Veterinary Reference Laboratory Market is accounted for $4.56 billion in 2023 and is expected to reach $9.65 billion by 2030 growing at a CAGR of 11.3% during the forecast period. A Veterinary Reference Laboratory (VRL) is a specialized facility with cutting-edge equipment and highly qualified veterinary professionals working there to diagnose and track the health of animals. These labs are vital resources for veterinarians and other animal health professionals because they offer prompt and accurate diagnostic services, blood chemistry analysis, microbiology, pathology, and genetic testing are just a few of the many tests that VRLs provide to help with the diagnosis and treatment of various animal diseases. They are vital resources that protect the health of animals, aid in research, and guarantee the welfare of domestic and wild animals.
According to the British Veterinary Association (BVA), Veterinary professionals are committed to promoting the health and welfare of animals, advancing veterinary science, and upholding high standards of professional conduct.
Increasing awareness of animal health
A growing number of stakeholders, including veterinary associations, animal welfare organizations, and governmental bodies, are working together to raise awareness about animal health. The purpose of these programs is to raise awareness among pet owners and livestock producers of the value of regular veterinary checkups and preventive healthcare measures. Additionally, the need for strong diagnostic services has been further highlighted by high-profile disease outbreaks in recent years, including avian influenza and bovine spongiform encephalopathy (BSE), which have highlighted the risks associated with compromised animal health and food safety.
High expense of cutting-edge diagnostic technologies
Veterinary Reference Laboratories faces a substantial financial hurdle in implementing new diagnostic technologies. The upfront costs associated with purchasing cutting-edge machinery, like automated analyzers and next-generation sequencing platforms, can be high. The operational costs are also increased by continuing expenditures for equipment upgrades, calibration, and maintenance. Furthermore, the financial burden is further increased by the need to hire and retain qualified staff that is adept at using and interpreting the data from these advanced technologies.
Growing requirement for diagnostic specialty services
Veterinary Reference Laboratories has the opportunity to broaden the scope of their services due to the growing complexity of veterinary care and the rise in the incidence of infectious and chronic diseases in animals. Specialized diagnostic tests, like molecular diagnostics, serology, and advanced imaging, are in greater demand as a means of enabling early disease detection, individualized treatment planning, and therapeutic efficacy monitoring. Moreover, labs can take advantage of this trend and set themselves apart in the market by investing in state-of-the-art technologies and building competence in specialized fields like genetic testing, infectious diseases, and oncology.
Pressure from in-house testing for competition
To increase turnaround times and client satisfaction, veterinary clinics and hospitals are investing more and more in internal diagnostic testing equipment. As a result of this trend, veterinary reference laboratories are at risk because fewer diagnostic tests are being contracted out to outside laboratories. Veterinary clinics may find that in-house testing is more practical and economical, especially when it comes to fast diagnostic assays and routine screenings. However, to lessen the impact of competition from in-house testing, Veterinary Reference Laboratories must set themselves apart from the competition by providing specialized tests, knowledge of intricate cases, and exceptional customer service.
The Veterinary Reference Laboratory market has been impacted by the COVID-19 pandemic. In the following phases of the pandemic, there has been a gradual recovery with changing trends, whereas the initial phase of the pandemic caused disruptions in laboratory operations, challenges in the supply chain, and decreased demand for non-essential veterinary services due to lockdown measures and economic uncertainties. The pandemic has increased demand for diagnostic testing services by highlighting the value of veterinary diagnostics in zoonotic disease surveillance, animal health monitoring, and ensuring food safety. Additionally, the demand for preventive healthcare procedures like wellness exams, vaccinations, and diagnostic screenings has increased due to the rise in pet ownership and the increased awareness of animal health and well-being during the pandemic.
The Clinical Pathology segment is expected to be the largest during the forecast period
It is projected that the clinical pathology segment will command the largest market share in the veterinary reference laboratory industry. Clinical pathology is a wide field of medicine that includes a variety of diagnostic procedures used to evaluate the health of animals by examining their tissues, cells, and bodily fluids. Hematology, biochemistry, urinalysis, cytology, and histopathology are a few of these tests. Furthermore, the diagnosis, surveillance, and treatment of a wide range of animal medical disorders, such as metabolic disorders, infectious diseases, immune-mediated disorders, and neoplastic diseases, depend heavily on clinical pathology.
The Pharmaceutical Companies segment is expected to have the highest CAGR during the forecast period
In the Veterinary Reference Laboratory market, the pharmaceutical company segment is projected to have the highest CAGR. Through the development and marketing of veterinary medications, vaccines, and biological products, pharmaceutical companies play a crucial role in veterinary medicine. For preclinical and clinical testing services to evaluate the safety, effectiveness, and caliber of their products, they depend on Veterinary Reference Laboratories. Moreover, reference laboratories and pharmaceutical companies work together on research and development projects that progress veterinary diagnostics and therapies.
North America usually holds the largest share, with strong regulatory frameworks and cutting-edge diagnostic technologies, the region has a well-established veterinary healthcare infrastructure that includes a high concentration of veterinary clinics, hospitals, and research institutions. The need for diagnostic testing services is driven in part by growing pet ownership, increased demand for companion animal healthcare services, and increased public awareness of zoonotic diseases in North America. Furthermore, deliberate efforts by governmental organizations, veterinary associations, and industry participants to advance preventive healthcare practices and improve animal welfare also contribute to the region's Veterinary Reference Laboratory market's steady expansion.
The Veterinary Reference Laboratory market is expected to grow at the highest CAGR in the Asia-Pacific region. Particularly in emerging economies like China, India, and Southeast Asian nations, the region is seeing rapid urbanization, economic development, and a shift toward companion animal ownership. The demand in the area for veterinary services, including diagnostic testing, is being driven by rising disposable incomes, evolving lifestyles, and an increasing consciousness of pet health. The adoption of advanced diagnostic technologies in veterinary healthcare is being driven by the expansion of livestock production and growing concerns about food safety and disease outbreaks. Moreover, the Veterinary Reference Laboratory market in Asia Pacific is expanding as a result of government initiatives to improve animal welfare, bolster regulatory frameworks, and modernize the infrastructure for animal healthcare.
Key players in the market
Some of the key players in Veterinary Reference Laboratory market include ProtaTek International Inc, GreenCross Limited, VCA Inc, ANTECH Diagnostics, Neogen Corporation, Thermo Fisher Scientific, Inc., IDEXX Laboratories, Inc., GD Animal Health, Marshfield Labs, Zoetis Inc, SYNLAB International GmbH, Heska Corporation, Texas A&M Veterinary Medical Diagnostic Laboratory and LABOKLIN GmbH.
In June 2023, Antech Diagnostics, Inc. made a proposal to acquire Heska Corporation from BlackRock, Inc., The Vanguard Group, Inc. and others for $1.4 billion on February 20, 2023. As part of consideration Antech Diagnostics will pay in all cash, at a price of $112.50 per share. On March 6, 2023, Mars submitted to Heska a revised written proposal to acquire Heska in an all-cash transaction at a price of $120 per share.
In April 2023, Neogen Chemicals Ltd., a manufacturer of Bromine-based and Lithium-based specialty chemicals, said it has signed an agreement with MU Ionic Solutions Corporation (MUIS), Japan, to acquire manufacturing technology licence for production of electrolytes in India. MUIS is a joint-venture between Mitsubishi Chemical Corporation (MCC) and UBE Corporation, a group company of The Mitsubishi Chemicals Group.
In February 2023, Thermo Fisher Scientific Inc. entered into a definitive agreement to acquire CorEvitas, a provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity, for $912.5 million in cash. CorEvitas will become part of Thermo Fisher's Laboratory Products and Biopharma Services segment. The transaction is expected to be completed by the end of 2023.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.